Form D · Pharmaceuticals

J2 Bio-Pharma, LLC

Wyncote, PA · CIK 0001677006

Offering snapshot reported Jan 22, 2019 · SEC filing

Reported sold
$345K
Offering amount: $800K
Investors reported
6
Form D · investor count
Minimum accepted
$100
Reported outside-investor minimum
First sale
Jun 15, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$173K$345KJun 17, 2016: $150,000.00Jun 17, 2016Jan 22, 2018: $345,000.00Jan 22, 2018Jan 22, 2019: $345,000.00Jan 22, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 22, 2019Amendment$345,000$0vs Jan 22, 20186SEC filing
Jan 22, 2018Amendment$345,000$195,000vs Jun 17, 20166SEC filing
Jun 17, 2016Initial$150,000No comparison1SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-265309
Common LLC Units

Source: Form D, filed Jan 22, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Fares Director, Executive
James Harris Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
648 Mulford Road
Wyncote, PA, 19095